ArticleCureus2025
Optimizing Recovery: Heliox Therapy for Post-extubation Stridor Management.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Post-extubation stridor poses a significant challenge in critical care settings, often necessitating prompt intervention to prevent respiratory compromise and potential reintubation. This case report details the successful management of post-extubation stridor in a 55-year-old female patient with a complex medical history, using heliox therapy. Heliox, a gas mixture of helium and oxygen, has emerged as a novel therapeutic option in such scenarios, owing to its ability to reduce airway resistance and improve gas flow dynamics. Following the patient's elective intubation for MRI imaging, she developed hoarseness, loud breathing, and stridor upon extubation, indicative of subglottic edema and bilateral vocal cord paralysis. Despite initial treatment with conventional modalities yielding minimal improvement, heliox therapy (70%/30%) with supplemental oxygen was initiated, resulting in significant alleviation of symptoms. Subsequent maintenance therapy with corticosteroids and bronchodilators further facilitated the resolution of respiratory distress. This case underscores the pivotal role of heliox therapy as an effective adjunct in managing post-extubation stridor, offering rapid relief and potentially obviating the need for reintubation. Moreover, it highlights the importance of innovative therapeutic approaches in optimizing outcomes for patients with respiratory distress in critical care settings. However, further research is warranted to elucidate the optimal utilization criteria and long-term efficacy of heliox therapy in this context.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.